Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet

Systemic inflammation is strongly involved in the pathophysiology of the metabolic syndrome, a cluster of metabolic risk factors that includes hypertriglyceridemia. Aspirin treatment lowers inflammation via inhibition of NF-κB activity but also reduces hypertriglyceridemia in humans. The aim of this...

Full description

Saved in:
Bibliographic Details
Main Authors: van Diepen, Janna A., Vroegrijk, Irene O. C. M., Berbée, Jimmy F. P., Shoelson, Steven E., Romijn, Johannes A., Havekes, Louis M., Rensen, Patrick C. N., Voshol, Peter J.
Format: Artigo
Language:Inglês
Published: American Physiological Society 2011
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116353/
https://ncbi.nlm.nih.gov/pubmed/21862721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00185.2011
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items